Monir Sadat Hakemi

Monir Sadat Hakemi

Auto-generated profile, based on publicly available information

Monir Sadat Hakemi

Department of Nephrology, Shariati Hospital Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2007 in Transplantation Proceedings
Verified
Journal Article
Closed access
MGM.R. Ganji
M.R. Ganji
MCM. Charkhchian
M. Charkhchian
MHM. Hakemi
M. Hakemi
GNG.H. Nederi
G.H. Nederi
TST. Solymanian
T. Solymanian
INI. Najafi
I. Najafi

2 February 2022 in Blood Purification
Verified
Journal Article
Closed access
PDF file
MHMonir Sadat Hakemi
Monir Sadat Hakemi
ANAmir Ahmad Nassiri
Amir Ahmad Nassiri
ANAli Nobakht
Ali Nobakht
MMMasoud Mardani
Masoud Mardani
IDIlad Alavi Darazam
Ilad Alavi Darazam
AKAnita Karimi
Anita Karimi
Introduction: Sepsis is defined as life-threatening organ dysfunction in result of the host’s dysregulated response to infection and septic shock. Sepsis-associated kidney injury is usually defined as concurrent presence of acute kidney injury (AKI) and sepsis without other significant causative factors. Method: The current retrospective study was conducted to elucidate beneficial and side effects of CytoSorb®. A total of 17 patients were primarily treated with continuous renal replacement therapy in combination with CytoSorb. The demand for norepinephrine, mean arterial pressure, lactate, and procalcitonin (PCT) levels, as well as ICU length of stay, was measured. Result: The blood lactate levels decreased by 32.30% when comparing mean levels before and after treatment. All patients who survived (n = 14) had reduction in vasopressor demand to 68.96% of their initial dose before the start of treatment. Hospital survival was greater in patients who initially had higher vasopressor demand compared to their nonsurviving counterparts, but in whom vasopressor dosages were reduced significantly during their treatments. Mortality as predicted by APACHE II score in the overall patient population was 79.9%, whereas, the observed ICU mortality was 31%. The baseline PCT levels on patients received 1, 2, and 3 CytoSorbs were 27.08 ± 5.81 ng/mL, 13.28 ± 2.62 ng/mL, and 21.03 ± 6.56 ng/mL, respectively. Observed PCT levels at 24 h after the last treatment on patients received 1, 2, and 3 CytoSorb were 31.55 ± 15.70 ng/mL, 5.61 ± 1.77 ng/mL, and 8.11 ± 3.62 ng/mL, respectively. Conclusion: In conclusion, it seems that applying the CytoSorb in combination with CRRT in ICU septic patients with AKI, is related to a significant decrease in mortality, if the integrity and continuity of the treatment be kept, as much as possible. This study presented an effectively positive outcome with cytokine adsorber treatment as an adjuvant along with standard treatment in a high-risk mortality case of septic shock with organ failure.

30 November 2020 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
PDF file
FYFatemeh Yaghoubi
Fatemeh Yaghoubi
MHMonirossadat Hakemi
Monirossadat Hakemi
HTHannaneh Taghizadeh
Hannaneh Taghizadeh
SASudabeh Alatab
Sudabeh Alatab
Introduction: Disorders of minerals metabolism are common metabolic problems in patients undergoing peritoneal dialysis (PD) which causes increase in mortality and morbidity in these patients. Objectives: In this study, the relationship between bone metabolic indices and mortality rate in patients on PD was assessed. Patients and Methods: Data were collected from Iranian peritoneal dialysis registry database, covering the period 2009–2015 and comprised 2000 adult patients. Patients with less than three months follow-up and incomplete data were excluded. Demographic and some laboratory data (including age, gender, body mass index, serum albumin, dialysis vintage and comorbidities) of patients recorded. Additionally, the unadjusted and adjusted, hazard ratios (HRs) of serum phosphorus (P), calcium (Ca) and parathyroid hormone (PTH) levels, to find their association with mortality were calculated, using the Cox proportional-hazards model. Results: In total, 1197 out of 2000 patients had the inclusion criteria and were included in the study. We found that serum iPTH (intact parathyroid hormone) over 600 pg/mL significantly increased the mortality rate by 2.7 times compared to iPTH levels between 200 to 600 pg/ mL (HR: 2.7, P=0.002). Additionally, the serum phosphorus level less than 4 mg/dL was significantly (P=0.0001) related to higher mortality rate (HR: 1.6). There was no significant association of serum calcium and alkaline phosphatase (ALP) levels with mortality (P > 0.05). Conclusion: Although high serum iPTH and low-serum phosphorus levels could determine the mortality risk in PD patients, Ca and ALP levels were not risk factors for mortality.

7 August 2026 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
FSFarnaz Saberian
Farnaz Saberian
MAMinoo Heidari Almasi
Minoo Heidari Almasi
ANAmirahmad Nassiri
Amirahmad Nassiri
MHMonir Sadat Hakemi
Monir Sadat Hakemi
HIHossein Imani
Hossein Imani
ASAntoine Schneider
Antoine Schneider

1 June 2024 in Alborz University Medical Journal
Verified
Journal Article
Open access
PDF file
MHMonir Sadat Hakemi
Monir Sadat Hakemi
FTFarnaz Tavakoli
Farnaz Tavakoli
EAEsmat Abdollahpour
Esmat Abdollahpour
YMYasin Masoudi
Yasin Masoudi
ANAmir Ahmad Nassiri
Amir Ahmad Nassiri
Background:Superior vena cava (SVC) stenosis is a major cause of vascular access problem and is associated with morbidity and mortality in hemodialysis patients. This study was done to determine the prevalence and risk factors for SVC stenosis in patients on HD by tunneled cuffed catheter (TCC) in Shariati hospital. Methods:All patients ...